A detailed history of Glen Eagle Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,108 shares of VTRS stock, worth $12,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,108
Holding current value
$12,919
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $18,029 - $21,563
-1,794 Reduced 61.82%
1,108 $11.8 Million
Q1 2024

Jul 03, 2024

BUY
$11.27 - $13.53 $32,705 - $39,264
2,902 New
2,902 $34.7 Million
Q4 2023

Aug 13, 2024

BUY
$8.77 - $10.85 $11,611 - $14,365
1,324 Added 53.82%
3,784 $41 Million
Q3 2023

Aug 13, 2024

SELL
$9.59 - $11.35 $5,360 - $6,344
-559 Reduced 18.52%
2,460 $24.3 Million
Q2 2023

Aug 13, 2024

BUY
$9.02 - $10.29 $4,591 - $5,237
509 Added 20.28%
3,019 $30.1 Million
Q1 2023

Aug 13, 2024

BUY
$9.2 - $12.26 $8,648 - $11,524
940 Added 59.87%
2,510 $24.1 Million
Q4 2022

Aug 13, 2024

SELL
$8.72 - $11.56 $706 - $936
-81 Reduced 4.91%
1,570 $17.5 Million
Q3 2022

Aug 13, 2024

SELL
$8.48 - $11.13 $10,930 - $14,346
-1,289 Reduced 43.84%
1,651 $14.1 Million
Q2 2022

Aug 13, 2024

BUY
$9.95 - $12.27 $9,910 - $12,220
996 Added 51.23%
2,940 $30.8 Million
Q1 2022

Aug 13, 2024

SELL
$9.81 - $15.4 $5,434 - $8,531
-554 Reduced 22.18%
1,944 $21.2 Million
Q4 2021

Aug 13, 2024

SELL
$12.09 - $14.68 $14,906 - $18,100
-1,233 Reduced 33.05%
2,498 $33.8 Million
Q3 2021

Aug 13, 2024

SELL
$13.25 - $15.13 $4,120 - $4,705
-311 Reduced 7.69%
3,731 $50 Million
Q2 2021

Aug 13, 2024

SELL
$12.97 - $16.15 $3,826 - $4,764
-295 Reduced 6.8%
4,042 $57.8 Million
Q1 2021

Aug 13, 2024

SELL
$13.59 - $18.54 $11,796 - $16,092
-868 Reduced 16.68%
4,337 $60.2 Million
Q4 2020

Aug 13, 2024

BUY
$14.3 - $18.74 $32,932 - $43,158
2,303 Added 79.36%
5,205 $97.5 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.